The monoclonal antibody is directed against the CD5-antigen (T1-antigen), which is expressed on human T lymphocytes. The nonoclonal antibody reacts with 90% of human peripheral T lymphocytes, medullary thymocytes as well as with lymphocytes of patients with chronic B-cell derived leukaemia.
| Target |
CD5 |
| Reactivity |
Human |
| Host |
Mouse |
| Clonality |
Monoclonal |
| Tested Applications |
FCM |
| Recommended dilutions |
FCM: 20 µl/1 million cells. Optimal dilutions/concentrations should be determined by the end user. |
| Immunogen |
Human T-acute lymphoblastic leukemia (ALL) cells. |
| Purification |
Affinity Chromatography |
| Form |
Liquid |
| Isotype |
IgG2a |
| Conjugation |
PE |
| Specificity |
This antibody identifies a 67 kDa lymphocyte surface antigen belonging to the CD5 cluster on peripheral blood T lymphocytes, 70% of thymocytes and a limited number of malignancies of T cell origin. The CD5 antigen is expressed on the majority of malignant B CLL, T CLL and T ALL cells and a proportion of B lymphoma cells. |
| Storage |
Aliquot and store in the dark at 2°C to 8°C. Avoid exposure to light. |
| Molecular Weight |
67 kDa |
| Swiss Prot |
P06127
|
| GeneID |
921
|
| Buffer |
The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide |
| UNSPSC Code |
12352203 |
| Availability |
Shipped within 3-5 working days. |
| Note |
This product is for research use only. |